Outcomes of kidney transplantation in patients with IgA nephropathy based on induction: A UNOS data analysis.
Emmanuel Albert Aydin-GhormozJason PerlmutterNaoru KoizumiJorge OrtizGeovani FaddoulPublished in: Clinical transplantation (2023)
In patients with IgAN requiring a kidney transplant, Alemtuzumab induction correlates with increased IgAN recurrence. Relapse significantly affects graft survival and mortality. ATG without steroids is associated with the least graft loss and mortality.